2010
DOI: 10.1016/j.rmed.2010.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Point-of-care Arkansas method for measuring adherence to treatment with isoniazid

Abstract: Summary We evaluated the accuracy of a point-of-care test designed to measure adherence to isoniazid (INH) preventive therapy in a hospital setting in Rio de Janeiro, Brazil. Patients on treatment with daily INH and patients not receiving INH were included. Sensitivity and specificity of the test were 84%/98% at the first minute, and 95%/98% at the fifth minute, respectively. Among smokers, sensitivity and specificity was reduced (80%/89% at the fifth minute, respectively), but only 17% smoked. This test accur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
29
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(29 citation statements)
references
References 9 publications
0
29
0
Order By: Relevance
“…This point-of-care test detects isoniazid and its metabolites in the patient's urine with high sensitivity and specificity [20], confirming whether isoniazid has been taken in the last 24 to 30 hours. It takes only 5 minutes to perform and does not require laboratory facilities, so can be undertaken in the patient's home.…”
Section: Methodsmentioning
confidence: 58%
“…This point-of-care test detects isoniazid and its metabolites in the patient's urine with high sensitivity and specificity [20], confirming whether isoniazid has been taken in the last 24 to 30 hours. It takes only 5 minutes to perform and does not require laboratory facilities, so can be undertaken in the patient's home.…”
Section: Methodsmentioning
confidence: 58%
“…Similarly, 75% of a South Indian population were slow acetylators [10]. Fast acetylation was postulated as an explanation for negative urine results at 24 h in five out of 94 patients after isoniazid ingestion, although acetylator status was not measured [4]. Using logistic regression analysis, we found no effect on Isoscreen results in five fast acetylators, whose individual results did not differ from others.…”
Section: Point-of-care Urine Test For Assessing Adherence To Isoniazimentioning
confidence: 61%
“…Purple or blue samples are deemed positive, green intermediate and yellow negative. High sensitivities and specificities have been reported, but without a consistent relationship to the timing of the previous dose of isoniazid or measurement of acetylator status [2,4].…”
Section: Point-of-care Urine Test For Assessing Adherence To Isoniazimentioning
confidence: 99%
“…The range of colours observed is reported in the Figure. Based on reports from previous studies, 3-7 and supported by high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS) findings, yellow was defined as negative, while the other colours in the Figure were recorded as positive.…”
Section: Study Population and Methodsmentioning
confidence: 98%
“…1 Adherence to therapy is important for efficacy. 2 The Arkansas method is a qualitative urine assay used to monitor isoniazid (INH) ingestion 3-7 by detecting urinary metabolites reacting with cyanogen chloride and barbituric acid, to produce a blue-purple dye indicating a positive reaction. 8 A limitation of the test is that its sensitivity decreases with increasing time after INH ingestion.…”
mentioning
confidence: 99%